Results for tag: "Meningococcal Conjugate"

The Meningococcal Conjugate Vaccine (MCV) is a type of vaccine used to protect against meningococcal disease, a serious bacterial infection that can cause meningitis and sepsis. MCV is typically administered to children and adolescents, and is recommended by the Centers for Disease Control and Prevention (CDC) for routine immunization. MCV is available in both monovalent and multivalent formulations, with the latter providing protection against multiple strains of the disease. MCV is typically administered as a series of two or three doses, depending on the age of the patient. The vaccine is generally well-tolerated, with the most common side effects being mild and short-lived. The MCV market is highly competitive, with a number of major pharmaceutical companies offering products. These include Pfizer, GlaxoSmithKline, Merck, Sanofi Pasteur, and Novartis. Show Less Read more